|
Mar 7
|
IGM Biosciences Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
|
|
Mar 1
|
Wall Street Analysts Think IGM Biosciences, Inc. (IGMS) Could Surge 63.1%: Read This Before Placing a Bet
|
|
Feb 26
|
Strength Seen in iTeos Therapeutics, Inc. (ITOS): Can Its 7.4% Jump Turn into More Strength?
|
|
Jan 16
|
IGM Bio (IGMS) Stock Rallies 142% in 3 Months: Here's Why
|
|
Dec 8
|
15 Best Falling Stocks To Buy Now
|
|
Dec 5
|
IGM Biosciences Announces Strategic Pipeline Prioritization and Cash Runway Extension
|
|
Dec 1
|
Bulletin from Extraordinary General Meeting in Medivir AB (publ)
|
|
Jul 3
|
IGM Announces Closing of Upsized Public Offering and Concurrent Private Placement and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
|
|
Jun 30
|
While hedge funds own 27% of IGM Biosciences, Inc. (NASDAQ:IGMS), individual investors are its largest shareholders with 28% ownership
|
|
May 2
|
IGM Biosciences to Present at Two Upcoming Investor Conferences
|
|
Apr 28
|
Bullish IGM Biosciences, Inc. (NASDAQ:IGMS) insiders filled their treasuries with US$1.6m worth of stock over last year
|